期刊簡介 | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Biomedicines LetPub Score 7.3
51 ratings
Rate
Reputation 8.3 Influence 6.1 Speed 9.7 | |||||||||||||||||||||
期刊簡稱 | BIOMEDICINES | |||||||||||||||||||||
ISSN | 2227-9059 | |||||||||||||||||||||
h-index | N.A. | |||||||||||||||||||||
CiteScore |
| |||||||||||||||||||||
自引率 (2023-2024) | 5.10%自引率趨勢 | |||||||||||||||||||||
掲載範囲 |
| |||||||||||||||||||||
官方網站 | https://www.mdpi.com/journal/biomedicines | |||||||||||||||||||||
在線稿件提交 | ||||||||||||||||||||||
開放訪問 | Yes | |||||||||||||||||||||
出版商 | Multidisciplinary Digital Publishing Institute (MDPI) | |||||||||||||||||||||
主題領域 | Biochemistry, Genetics and Molecular Biology | |||||||||||||||||||||
出版國/地區 | SWITZERLAND | |||||||||||||||||||||
發行頻率 | ||||||||||||||||||||||
創刊年 | 0 | |||||||||||||||||||||
每年文章數 | 3294每年文章數趨勢 | |||||||||||||||||||||
黃金OA百分比 | 99.65% | |||||||||||||||||||||
OA Related Info | APC: Yes( CHF2600; ) APC waiver:Check Notes Other charges: No Keywords: biological active substances、quality and safety of biological pharmaceutical products、gene therapy、challenges in administration of biomedicines、development of biomedicines、production of biomedicines Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | |||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| |||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | |||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2227-9059%5BISSN%5D | |||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: 8 Weeks | |||||||||||||||||||||
競爭力 * | 來自作者的數據: | |||||||||||||||||||||
參考鏈接 |
| |||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[Biomedicines] 的評論 | 撰寫評論 |
作者: zyl1994 領域: 医学 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2022-06-13 16:51:04 評論於 It may be because you work in a hospital and have seen reports before that MDPI is not easily accepting submissions from domestic medical units. I submitted to a university, and I don't know any editors. Some were rejected immediately, while others were accepted after revisions. Overall, I feel that it is relatively formal.(0) 讚! | zyl1994 |
作者: 猫猫小女子 領域: 生物学 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2021-08-21 11:54:37 評論於 When I submitted my first article, it was rejected. After making revisions, I submitted it again and it was rejected once more. I was not satisfied and added some experiments before submitting it again. Finally, it was accepted. Now, the impact factor of this journal has exceeded 6. I feel that it is becoming increasingly difficult to submit articles. I estimate that it may drop in the ranking next year, but I am optimistic about the potential increase in the impact factor.(0) 讚! | 猫猫小女子 |
作者: 猫猫小女子 領域: 医学 審稿時間: 1.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-03-20 05:18:56 評論於 It's not that I'm saying anything, I work in oncology. I submitted my paper to this journal unexpectedly, and it got published. I didn't intentionally aim for this journal, but the review process was very fast. There were two reviewers and one research editor, and they provided a lot of comments. The key point is that their feedback was very professional. I even suspected that my field might have ended up in the hands of these three individuals. One reviewer seemed like they were rejecting the paper, while the other two suggested major revisions. The editor ultimately decided on major revisions and requested additional experiments. After 20 days, I resubmitted the revised paper, and it underwent another round of major revisions, although the changes were not extensive. I don't think it can be considered as a major revision. I resubmitted it within 10 days, and I will receive the results in the next couple of days. Overall, I feel that this journal is quite professional. Once you see the reviewers' comments, you will understand. They pointed out everything that you might be afraid of being asked, which made me quite nervous. Although the publication fee is expensive, I still hope for acceptance. After all, the revisions were quite difficult. I will come back with good news if there is any, and if there is no news, it means bad news.(16) 讚! | 猫猫小女子 |
作者: ritsu 領域: 医学 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2020-12-19 10:20:10 評論於 It was submitted as an solicit manuscript. The review comments were returned one month after submission. There were 3 reviewers. It was accepted one week after minor revision submitted. The IF is going to rise, with a high probability of reaching 5.5 next year. (13) 讚! | ritsu |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us